Public-registry trials using SMP-656 Injection that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| SMP-656 for HER2-Positive Advanced Breast Cancer | Chengdu SciMount Pharmatech Co., Ltd. | HER2-positive Breast Cancer | PHASE2 | 15 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →